Differentiation-Chronology Specific Function of DNMT1 and Selective Anti-Leukemia Stem-Cell Therapy

被引：0
|
作者：
Negrotto, Soledad [1 ]
Hu, Zhenbo [1 ]
Link, Kevin A. [2 ]
Duong, Hien [1 ]
Schade, Andrew E.
Maciejewski, Jaroslaw P. [1 ]
Mulloy, James C. [2 ]
Saunthararajah, Yogenthiran [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Ctr, Expt Hematol & Hematopoiesis Sect, Cleveland, OH 44106 USA
[2] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：81 / 82
页数：2
相关论文
共 31 条
  • [21] Comparison of Wilms’ tumor antigen 1-specific T lymphocyte generation soon after nonmyeloablative allergenic stem-cell transplantation in acute and chronic leukemia patients
    Wei Li
    Zuo HongLi
    Sun XueDong
    Liu TieQiang
    Guo Mei
    Liu GuangXian
    Sun QiYun
    Qiao JianHui
    Wang DanHong
    Yu ChangLin
    Hu KaiXun
    Dong Zheng
    Ai HuiSheng
    International Journal of Hematology, 2010, 91 : 652 - 660
  • [22] DISCOVERY OF TSC-100: A NATURAL HA-1-SPECIFIC TCR TO TREAT LEUKEMIA FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANT THERAPY
    Nayar, Ribhu
    Jangalwe, Sonal
    Jurewicz, Mollie
    Boudot, Antoine
    Basinski, Andrew
    Prenovitz, Robert
    Olesin, Elizabeth
    Pollacksmith, Daniel
    Xu, Qikai
    Wang, Yifan
    Virbasius, Amy
    Li, Jeffery
    Whitton, Holly
    Dunlap, Garrett
    Cristofaro, Alexander
    Nabilsi, Nancy
    Zhang, Ruan
    Perullo, Candace
    Liao, Sida
    Jahan, Kenneth
    Olivier, Kenneth
    MacBeath, Gavin
    MacBeath, Gavin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A94 - A95
  • [23] Pilot Use of a Novel DNA Methytransferase-1 (DNMT1) Flow Cytometric Pharmacodynamic Assay to Evaluate Response to Low-Dose Azacitidine Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Hematopoietic Cell Transplantation
    El Jurdi, Najla H.
    Ueda, Masumi
    Woost, Philip
    Lazarus, Hillard M.
    Caimi, Paolo
    Cooper, Brenda W.
    Creger, Richard
    Little, Jane A.
    Baer, Linda
    Brister, Lauren
    Malek, Ehsan
    Metheny, Leland
    Otegbeye, Folashade
    Tomlinson, Ben K.
    William, Basem M.
    Jacobberger, James
    De Lima, Marcos
    BLOOD, 2017, 130
  • [24] Anti-Leukemia Activity of the Selective BCL-2 Inhibitor ABT-199 in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia Is Characterized By MCL-1/BCL-2 Expression Serving As Biomarker for Treatment Response
    Seyfried, Felix
    Demir, Salih
    Horl, Rebecca
    Kohrer, Stefan
    Scheffold, Annika
    Stilgenbauer, Stephan
    Debatin, Klaus-Michael
    Meyer, Luder Hinrich
    BLOOD, 2016, 128 (22)
  • [25] PHASE-II TRIAL OF I-131 B1 (ANTI-CD20) ANTIBODY THERAPY WITH AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR RELAPSED B-CELL LYMPHOMAS
    PRESS, OW
    EARY, JF
    APPELBAUM, FR
    MARTIN, PJ
    NELP, WB
    GLENN, S
    FISHER, DR
    PORTER, B
    MATTHEWS, DC
    GOOLEY, T
    BERNSTEIN, ID
    LANCET, 1995, 346 (8971): : 336 - 340
  • [26] SEQUENTIAL HIGH-DOSE THERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA WITH BLOOD STEM-CELL AUTOGRAFTING AND MAINTENANCE CHEMOTHERAPY IN 1ST REMISSION RESERVING ALLOGRAFTING FOR 2ND REMISSION
    POWLES, R
    MEHTA, J
    SINGHAL, S
    WILLIAMS, H
    MATTHEY, F
    LUMLEY, H
    POLLARD, C
    SAMARATUNGA, I
    LAKHANI, A
    TRELEAVEN, J
    BLOOD, 1994, 84 (10) : A213 - A213
  • [27] Anti CD19 CART Therapy Following Allogenic Hematopoietic Stem Cell Transplantation Improved the Survival of Patients with BCR::ABL1-like Acute Lymphoblastic Leukemia
    Dai, Haiping
    Cui, Wei
    Shen, Hongjie
    Wang, Qian
    Yin, Jia
    Li, Zheng
    Wu, Depei
    Tang, Xiaowen
    BLOOD, 2022, 140 : 10345 - 10346
  • [28] THERAPY-INDUCED PH1 SUPPRESSION IN CHRONIC MYELOID-LEUKEMIA - MOLECULAR AND CYTOGENETIC STUDIES IN PATIENTS TREATED WITH ALPHA-2B IFN, HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL INFUSION
    LOCOCO, F
    MANDELLI, F
    DIVERIO, D
    ALIMENA, G
    DEFABRITIIS, P
    MELONI, G
    CEDRONE, M
    FRONTANI, M
    GUERRASIO, A
    SAGLIO, G
    BONE MARROW TRANSPLANTATION, 1990, 6 (04) : 253 - 258
  • [29] Preclinical evaluation of CB-012, an allogeneic anti-CLL-1 CAR-T cell therapy, that exhibits specific and potent toxicity in acute myeloid leukemia (AML) xenograft models
    Francica, Brian
    Garner, Elizabeth
    Namburi, Sai
    Colgan, Cian
    Fowler, Tristan
    Mutha, Devin
    Aviles, Art
    Stanaway, Morena
    Guo, Raymond
    An, Zili
    Kelly, Erin
    Degagne, Emilie
    Kwong, George
    Edwards, Leslie
    Jakes, Emma
    Shaw, Mckay
    Schilling, Benjamin
    Huynh, Jeremy
    Luu, Ricky
    Sidorov, Max
    Mousali, Rhonda
    Otsmaa, Mikk
    Lauer, Peter
    Skoble, Justin
    Kanner, Steven
    CANCER RESEARCH, 2024, 84 (06)
  • [30] Redirected CD4+ T Cells Using WT1-Specific T-Cell Receptor Gene Transfer Can Supply Multifactorial Help to Enhance the Anti-Leukemia Reactivity Mediated by Similarly Redirected CD8+ T Cells Using the Identical Gene Transfer
    Ochi, Toshiki
    Fujiwara, Hiroshi
    Okamoto, Sachiko
    Asai, Hiroaki
    Miyazaki, Yukihiro
    Shirakata, Toshiaki
    Mineno, Junichi
    Kuzushima, Kiyotaka
    Shiku, Hiroshi
    Yasukawa, Masaki
    BLOOD, 2011, 118 (21) : 295 - 295
1234